产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 10mg | 97% | 询价 | |||
| 25mg | 97% | 询价 | |||
| 50mg | 97% | 询价 | |||
| 100mg | 97% | 询价 | |||
| 250mg | 97% | 询价 | |||
| 1g | 97% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 10mg | 97% | 询价 | |||
| 25mg | 97% | 询价 | |||
| 50mg | 97% | 询价 | |||
| 100mg | 97% | 询价 | |||
| 250mg | 97% | 询价 | |||
| 1g | 97% | 询价 |
CAS No. |
105331-00-8 |
|---|---|
中文名称 |
4,6-二氨基-1-((2R,3R,4S,5R)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-基)-1,3,5-三嗪-2(1H)-酮 |
英文名称 |
4,6-Diamino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,3,5-triazin-2(1H)-one |
别名 |
6-AMino-5-azacytidine;4,6-Diamino-1-beta-D-ribofuranosyl-1,3,5-triazin-2(1H)-one;4,6-Diamino-1-(β-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one;4,6-diamino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,3,5-triazin-2(1H)-one;4,6-diamino-1-((2R,3R,4S,5R);1,3,5-Triazin-2(1H)-one, 4,6-diamino-1-β-D-ribofuranosyl-;Azacitidine Impurity ABCDEFG;6-Amino-5-azacytidine formate salt |
标准英文名 |
4,6-diamino-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,3,5-triazin-2(1H)-one |
分子式 |
C8H13N5O5 |
分子量 |
259.22 |
精确分子量 |
259.09 |
SMILES |
OC[C@@H]1[C@H]([C@H]([C@H](N2C(N=C(N=C2N)N)=O)O1)O)O |
标准SMILES |
NC1N=C(N)N([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(=O)N=1 |
性状 |
Solid |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Danger |
InChIKey |
HHBIDXKTBPRKSK-TXICZTDVSA-N |
危险类别(旧) |
H302 |
存储要求 |
Keep in dark place, Inert atmosphere, 2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral,Germ cell mutagenicity (Category 1A, 1B),Carcinogenicity (Category 1A, 1B) |
|---|---|
UN No. |
2811,2811,2811 |
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|